Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis
AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH). METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and un...
Saved in:
Published in | World journal of gastroenterology : WJG Vol. 15; no. 41; pp. 5193 - 5199 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Third Department of Internal Medicine, Nara Medical University, Shijo-cho 840, Kashihara, Nara 634-8522,Japan
07.11.2009
The WJG Press and Baishideng |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | AIM: To elucidate the possible crosstalk between angiogenesis, cytokeratin-18 (CK-18), and insulin resistance (IR) especially in patients with non-alcoholic steatohepatitis (NASH). METHODS: Twenty-eight patients with NASH and 11 with simple fatty liver disease (FL) were enrolled in this study and underwent clinicopathological examination. The measures of angiogenesis, CK-18, and IR employed were CD34-immunopositive vessels, CK-18- immunopositive cells, and homeostasis model assessment of IR (HOMA-IR), respectively. The correlations of these factors with NASH were elucidated. RESULTS: Significant development of hepatic neo- vascularization was observed only in NASH, whereas almost no neovascularization could be observed in FL and healthy liver. The degree of angiogenesis was almost parallel to liver fibrosis development, and both parameters were positively correlated. Similarly, CK-18 expression and HOMA-R were significantly increased in NASH as compared with FL and healthy liver. Further- more, CK-18 and HOMA-IR were also positively corre- lated with the degree of neovascularization. CONCLUSION: These results indicate that the crosstalk between angiogenesis, CK-18, and IR may play an important role in the onset and progression of NASH. |
---|---|
Bibliography: | Q578 Angiogenesis Angiogenesis; Cytokeratin-18; Fatty liver; Insulin resistance; Non-alcoholic steatohepatitis; Liver fibrosis Fatty liver 14-1219/R Q463 Cytokeratin-18 Insulin resistance Liver fibrosis Non-alcoholic steatohepatitis ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Telephone: +81-744-223051 Fax: +81-744-247122 Correspondence to: Dr. Hitoshi Yoshiji, Third Department of Internal Medicine, Nara Medical University, Shijo-cho 840, Kashihara, Nara 634-8522, Japan. yoshijih@naramed-u.ac.jp Author contributions: Kitade M and Yoshiji H acquired the clinical cases and patient consent, conceived the study, participated in its design, assisted in data collection, coordinated and helped draft the manuscript; Yoshiji H undertook the literature search and contributed to the writing and article review; Noguchi R, Ikenaka Y, Kaji K, Shirai Y, Yamazaki M, Uemura M, Yamao J, Fujimoto M, Mitoro A, Toyohara M, Sawai M, Yoshida M, Morioka C, Tsujimoto T, Kawaratani H and Fukui H were responsible for diagnosis, patient management and review; all authors read and approved the final manuscript. |
ISSN: | 1007-9327 2219-2840 |
DOI: | 10.3748/wjg.15.5193 |